These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6082294)

  • 1. Immunotherapy of leukemia: the use of different classes of immune lymphocytes.
    Alexander P
    Cancer Res; 1967 Dec; 27(12):2521-6. PubMed ID: 6082294
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity in malignant disease.
    Fairley GH
    Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
    [No Abstract]   [Full Text] [Related]  

  • 3. Passive antibody delays development of cell-mediated immunity in rats receiving renal allografts.
    Biesecker JL; Fitch FW; Rowley DA; Stuart FP
    Transplant Proc; 1973 Mar; 5(1):667-9. PubMed ID: 4572125
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to malignant disease in man.
    Fairley GH
    Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy of cancer].
    Lascano FD; Mazzei JA; Estevez ME
    Prensa Med Argent; 1971 Mar; 58(2):75-91. PubMed ID: 4103879
    [No Abstract]   [Full Text] [Related]  

  • 6. Summary: immunology of acute leukemia and Burkitt's tumor.
    Southam CM
    Cancer Res; 1967 Dec; 27(12):2554-6. PubMed ID: 4866768
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of immunology in the treatment of leukemias and hematosarcomas.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
    Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte transfer factor.
    Thompson RB
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):201-4. PubMed ID: 4397550
    [No Abstract]   [Full Text] [Related]  

  • 9. "Immune" RNA--a new model for the immunotherapy of cancer.
    Pilch YH
    Cancer Chemother Rep 3; 1973 Mar; 4(2):287-92. PubMed ID: 4729332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological treatment of leukemias].
    Szmigiel Z
    Pol Tyg Lek; 1971 Mar; 26(13):482-4. PubMed ID: 4929907
    [No Abstract]   [Full Text] [Related]  

  • 11. Some biologic, immunogenic, and morphologic effects in mice after infection with a murine sarcoma virus. I. Biologic and immunogenic studies.
    Law LW; Ting RC; Stanton MF
    J Natl Cancer Inst; 1968 May; 40(5):1101-12. PubMed ID: 5648135
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
    Mathé G; Thompson RB
    Dis Colon Rectum; 1973; 16(5):341-57. PubMed ID: 4590448
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor immunity: impairment in tumor-bearing hosts.
    Bernstein ID; Wepsic HT; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1971 Apr; 46(4):873-80. PubMed ID: 4324817
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic enhancement.
    Snell GD
    Surg Gynecol Obstet; 1970 Jun; 130(6):1109-19. PubMed ID: 4914604
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protection against runting disease by immunologic facilitation (enhancement phenomenon) induced passively and actively].
    Voisin GA; Kinsky R; Maillard J
    Ann Inst Pasteur (Paris); 1967 Oct; 113(4):521-47. PubMed ID: 6057335
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor immunology].
    Milas L; Silobrcić V
    Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
    [No Abstract]   [Full Text] [Related]  

  • 17. Passive serologic transfer of immunity to skin grafts in allogeneic and isogeneic mice.
    Kinne DW; Simmons RL
    Rev Surg; 1971; 28(1):68. PubMed ID: 4925865
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and humoral aspects of heterotransplantation immunity.
    Akiyama T
    Tohoku J Exp Med; 1966 Aug; 89(4):363-74. PubMed ID: 4291056
    [No Abstract]   [Full Text] [Related]  

  • 19. The specificity of antilymphocyte sera to thymic, splenic, and leukemic lymphocytes.
    Asakuma R; Reif AE
    Cancer Res; 1968 Apr; 28(4):707-15. PubMed ID: 5649060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoreactions in leukaemias with respect to immunotherapeutic trials (author's transl)].
    Libánský J
    Cas Lek Cesk; 1974 Feb; 113(5):141-5. PubMed ID: 4434427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.